July 16, 2009 3:57 PM
- Text
"Bribe" or No, Pfizer May Get Its Way in Philippines
(MoneyWatch) President Gloria Macapagal-Arroyo of the Philippines said she will consider the interests of foreign investors and other "satisfactory" proposals before signing a maximum retail price law that would impose price caps on drugs in the archipelago nation.
The news will cheer Pfizer, which attended a controversial meeting with the government there in which the company offered alternatives to price caps. Politicians in the Philippines allege that the offer -- of discount cards and posters for the president -- a "bribe." Pfizer denies the offer was a bribe. The Inquirer reported:
The news will cheer Pfizer, which attended a controversial meeting with the government there in which the company offered alternatives to price caps. Politicians in the Philippines allege that the offer -- of discount cards and posters for the president -- a "bribe." Pfizer denies the offer was a bribe. The Inquirer reported:
Malacaņang on Wednesday said President Gloria Macapagal-Arroyo would first take into account keeping foreign investors and ensuring public access to cheaper drugs before ordering a price ceiling for essential medicines.There is a July 18 deadline for Arroyo to complete the list of drugs facing price caps and sign the law.
The Palace was apparently backtracking on its tough position on Tuesday that Ms Arroyo was set to sign the executive order imposing maximum retail prices (MRP) by next week.
"If the drug companies do not come out with a response she deems satisfactory, then we might expect her at that point to go ahead with the maximum price ceiling regime," [a presdeintial spokesman] said.
- Previously:
- Pfizer "Bribe" Scandal in Philippines Heats Up; Company Offered Posters to the President
- UPDATED: Pfizer Accused of "Bribe" to Stave Off Price Control Law in Philippines
- Pfizer Catches Flak for Giving Drug Discounts to Some But Not All Filipinos
- Pfizer to Close S.F. Biotech Center in Favor of Unit Accused in Patent Suit
- Pfizer Patent Suit Could Make Elan Bapineuzamab Talks Go a Whole Lot Easier
- Pfizer's Foreign Viagra Ads: Mailman Jokes; Space Sperm and the Fountain of Youth
- Pfizer's Off-Label Bextra Team Was Called "The Highlanders"
- Pfizer Exec: Company Approved of Off-Label Bextra Promotion
Latest Now in MoneyWatch
- Ohio unemployment hits 3-year-low
- Jill on Money: Retirement investing, allocation, long term care
- Could "web-lining" be dangerous?
- Insurers respond cautiously to contraceptive plan
- Judge: Legally, breastfeeding not related to pregnancy
- Budget deficit drops to $27 billion in January
- Why the Powerball Jackpot is part of my investment strategy
- Is the new VW Beetle diesel worth the money?
- Consumer sentiment highlights risks to recovery
- Valentine blues? 10 best cities to be single
- December trade deficit widens to $48.8 billion
- Alcatel-Lucent returns to profit in 2011
- 6 things never to say in a performance review
- $26B mortgage deal: Who gets the money?
- Friendly's CEO steps down
- Quarterly loss hits $3.3B at Postal Service
- Greeks rail against cuts as EU demands more
Latest CBS News Headlines
on Facebook
on CBS News
- Key dates from Whitney Houston's life and work
- Houston remembered at Clive Davis gala
- Dudley leads Suns past Kings 98-84
- Houston remembered at Clive Davis gala
on Facebook
- Adele sings a cappella for Anderson Cooper
- Occupy protestors kicked out of CPAC
- CPAC: Will Sarah Palin spring a surprise?
- Beyonce and Jay-Z post first photos of Blue Ivy Carter
on CBS News






